{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:19:45Z","timestamp":1787915985326,"version":"build-2784847793"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230001, 82270199, 82400228, and U24A20680"],"award-info":[{"award-number":["82230001, 82270199, 82400228, and U24A20680"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76152-9","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:35:31Z","timestamp":1785292531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell profiling of natural killer\/T-cell lymphoma reveals stratified immune features and potential therapeutic implications"],"prefix":"10.1038","volume":"17","author":[{"given":"Yi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5110-1976","authenticated-orcid":false,"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-1520","authenticated-orcid":false,"given":"Yuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-5049","authenticated-orcid":false,"given":"Jie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9090-1907","authenticated-orcid":false,"given":"Huiqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1526-1043","authenticated-orcid":false,"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinna","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenrui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-1616","authenticated-orcid":false,"given":"Weili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5343-4652","authenticated-orcid":false,"given":"Wenlong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5447-3282","authenticated-orcid":false,"given":"Qingqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"76152_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland, K. R., Armitage, J. O. & Hancock, B. W. Non-Hodgkin lymphoma. Lancet 380, 848\u2013857 (2012).","journal-title":"Lancet"},{"key":"76152_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-023-01483-9","volume":"16","author":"XP Tian","year":"2023","unstructured":"Tian, X. P. et al. Novel target and treatment agents for natural killer\/T-cell lymphoma. J. Hematol. Oncol. 16, 78 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"76152_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-024-01782-8","volume":"9","author":"J Xiong","year":"2024","unstructured":"Xiong, J. et al. Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma. Signal Transduct. Target Ther. 9, 62 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"76152_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41392-020-00331-3","volume":"5","author":"J Cai","year":"2020","unstructured":"Cai, J. et al. Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer\/T cell lymphoma. Signal Transduct. Target Ther. 5, 289 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"76152_CR5","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1016\/S2352-3026(24)00066-8","volume":"11","author":"XP Tian","year":"2024","unstructured":"Tian, X. P. et al. First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer\/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial. Lancet Haematol. 11, e336\u2013e344 (2024).","journal-title":"Lancet Haematol."},{"key":"76152_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","volume":"37","author":"J Xiong","year":"2020","unstructured":"Xiong, J. et al. Genomic and transcriptomic characterization of natural killer T cell lymphoma. Cancer Cell 37, 403\u2013419.e406 (2020).","journal-title":"Cancer Cell"},{"key":"76152_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0046-8177(99)90147-8","volume":"30","author":"L Quintanilla-Martinez","year":"1999","unstructured":"Quintanilla-Martinez, L. et al. Histological and immunophenotypic profile of nasal NK\/T cell lymphomas from Peru: high prevalence of p53 overexpression. Hum. Pathol. 30, 849\u2013855 (1999).","journal-title":"Hum. Pathol."},{"key":"76152_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ijc.25969","volume":"130","author":"H Ishii","year":"2012","unstructured":"Ishii, H. et al. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer\/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15. Int J. Cancer 130, 48\u201358 (2012).","journal-title":"Int J. Cancer"},{"key":"76152_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2019.05.003","volume":"75","author":"ML Suv\u00e0","year":"2019","unstructured":"Suv\u00e0, M. L. & Tirosh, I. Single-cell RNA sequencing in cancer: lessons learned and emerging challenges. Mol. Cell 75, 7\u201312 (2019).","journal-title":"Mol. Cell"},{"key":"76152_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303913","volume":"10","author":"YQ Li","year":"2023","unstructured":"Li, Y. Q. et al. Single-cell analysis reveals that malignant cells reshape the cellular landscape and foster an immunosuppressive microenvironment of extranodal NK\/T-cell lymphoma. Adv. Sci. 10, e2303913 (2023).","journal-title":"Adv. Sci."},{"key":"76152_CR11","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.scib.2023.09.029","volume":"68","author":"J Xiong","year":"2023","unstructured":"Xiong, J. et al. GPCR signaling contributes to the immune characteristics of the microenvironment and the process of EBV-induced lymphomagenesis. Sci. Bull. 68, 2607\u20132619 (2023).","journal-title":"Sci. Bull."},{"key":"76152_CR12","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s43018-024-00807-z","volume":"5","author":"X Chu","year":"2024","unstructured":"Chu, X. et al. Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms. Nat. Cancer 5, 1409\u20131426 (2024).","journal-title":"Nat. Cancer"},{"key":"76152_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"DZ Guo","year":"2024","unstructured":"Guo, D. Z. et al. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Mol. Cancer 23, 157 (2024).","journal-title":"Mol. Cancer"},{"key":"76152_CR14","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41590-022-01312-0","volume":"23","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis. Nat. Immunol. 23, 1484\u20131494 (2022).","journal-title":"Nat. Immunol."},{"key":"76152_CR15","doi-asserted-by":"crossref","unstructured":"Marco Salas, S. et al. Optimizing Xenium In Situ data utility by quality assessment and best-practice analysis workflows. Nat. Methods 22, 813\u2013823 (2025).","DOI":"10.1038\/s41592-025-02617-2"},{"key":"76152_CR16","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"76152_CR17","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611\u20131624.e1624 (2017).","journal-title":"Cell"},{"key":"76152_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/cells5020014","volume":"5","author":"FD Herrington","year":"2016","unstructured":"Herrington, F. D. & Nibbs, R. J. Regulation of the adaptive immune response by the I\u03baB family protein Bcl-3. Cells 5, 14 (2016).","journal-title":"Cells"},{"key":"76152_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02022-x","volume":"23","author":"T Redmer","year":"2024","unstructured":"Redmer, T. et al. JUN mediates the senescence-associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression. Mol. Cancer 23, 114 (2024).","journal-title":"Mol. Cancer"},{"key":"76152_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cytogfr.2016.02.001","volume":"31","author":"MG Ertosun","year":"2016","unstructured":"Ertosun, M. G., Hapil, F. Z. & Osman Nidai, O. E2F1 transcription factor and its impact on growth factor and cytokine signaling. Cytokine Growth Factor Rev. 31, 17\u201325 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"76152_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1681\/ASN.2022050598","volume":"34","author":"PX Medina Rangel","year":"2023","unstructured":"Medina Rangel, P. X. et al. Cell cycle and senescence regulation by podocyte histone deacetylase 1 and 2. J. Am. Soc. Nephrol. 34, 433\u2013450 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"76152_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s13238-013-2084-3","volume":"4","author":"Y Fan","year":"2013","unstructured":"Fan, Y., Mao, R. & Yang, J. NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4, 176\u2013185 (2013).","journal-title":"Protein Cell"},{"key":"76152_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"76152_CR24","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ccell.2023.06.005","volume":"41","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell 41, 1407\u20131426.e1409 (2023).","journal-title":"Cancer Cell"},{"key":"76152_CR25","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1158\/0008-5472.CAN-21-4141","volume":"82","author":"L Jenkins","year":"2022","unstructured":"Jenkins, L. et al. Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade. Cancer Res. 82, 2904\u20132917 (2022).","journal-title":"Cancer Res."},{"key":"76152_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14273-0","volume":"11","author":"A Reuben","year":"2020","unstructured":"Reuben, A. et al. Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nat. Commun. 11, 603 (2020).","journal-title":"Nat. Commun."},{"key":"76152_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-024-01799-z","volume":"9","author":"B Cheng","year":"2024","unstructured":"Cheng, B. et al. The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial. Signal Transduct. Target Ther. 9, 93 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"76152_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank, C. U. et al. Defining \u2018T cell exhaustion. Nat. Rev. Immunol. 19, 665\u2013674 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"76152_CR29","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"76152_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496\u2013502 (2019).","journal-title":"Nature"},{"key":"76152_CR31","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408\u20131414 (2020).","journal-title":"Nat. Biotechnol."},{"key":"76152_CR32","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","volume":"39","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell 39, 1578\u20131593.e1578 (2021).","journal-title":"Cancer Cell"},{"key":"76152_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev, A. et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39, 845\u2013865.e847 (2021).","journal-title":"Cancer Cell"},{"key":"76152_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhep.2024.02.009","volume":"81","author":"P Xie","year":"2024","unstructured":"Xie, P. et al. CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma. J. Hepatol. 81, 93\u2013107 (2024).","journal-title":"J. Hepatol."},{"key":"76152_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ccell.2023.12.005","volume":"42","author":"M Benguigui","year":"2024","unstructured":"Benguigui, M. et al. Interferon-stimulated neutrophils as a predictor of immunotherapy response. Cancer Cell 42, 253\u2013265.e212 (2024).","journal-title":"Cancer Cell"},{"key":"76152_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/hon.3088","volume":"41","author":"HY Cao","year":"2023","unstructured":"Cao, H. Y., Li, L., Xue, S. L. & Dai, H. P. Chidamide: targeting epigenetic regulation in the treatment of hematological malignancy. Hematol. Oncol. 41, 301\u2013309 (2023).","journal-title":"Hematol. Oncol."},{"key":"76152_CR37","doi-asserted-by":"publisher","first-page":"e001696","DOI":"10.1136\/jitc-2020-001696","volume":"9","author":"Y Que","year":"2021","unstructured":"Que, Y. et al. Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma. J. Immunother. Cancer 9, e001696 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"76152_CR38","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","volume":"383","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals, M., Brito-Zer\u00f3n, P., L\u00f3pez-Guillermo, A., Khamashta, M. A. & Bosch, X. Adult haemophagocytic syndrome. Lancet 383, 1503\u20131516 (2014).","journal-title":"Lancet"},{"key":"76152_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF02982065","volume":"74","author":"N Takahashi","year":"2001","unstructured":"Takahashi, N., Miura, I., Chubachi, A., Miura, A. B. & Nakamura, S. A clinicopathological study of 20 patients with T\/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK\/T-cell lymphoma. Int J. Hematol. 74, 303\u2013308 (2001).","journal-title":"Int J. Hematol."},{"key":"76152_CR40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nm.4456","volume":"24","author":"H Wen","year":"2018","unstructured":"Wen, H. et al. Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK\/T cell lymphoma. Nat. Med. 24, 154\u2013164 (2018).","journal-title":"Nat. Med."},{"key":"76152_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","volume":"267","author":"G Soria","year":"2008","unstructured":"Soria, G. & Ben-Baruch, A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 267, 271\u2013285 (2008).","journal-title":"Cancer Lett."},{"key":"76152_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41584-023-01053-w","volume":"20","author":"E Landy","year":"2024","unstructured":"Landy, E., Carol, H., Ring, A. & Canna, S. Biological and clinical roles of IL-18 in inflammatory diseases. Nat. Rev. Rheumatol. 20, 33\u201347 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"76152_CR43","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle, E. & Massagu\u00e9, J. Transforming growth Factor-\u03b2 signaling in immunity and cancer. Immunity 50, 924\u2013940 (2019).","journal-title":"Immunity"},{"key":"76152_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1152\/physrev.00045.2017","volume":"99","author":"C Dostert","year":"2019","unstructured":"Dostert, C., Grusdat, M., Letellier, E. & Brenner, D. The TNF family of ligands and receptors: communication modules in the immune system and beyond. Physiol. Rev. 99, 115\u2013160 (2019).","journal-title":"Physiol. Rev."},{"key":"76152_CR45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMra2314005","volume":"392","author":"JI Henter","year":"2025","unstructured":"Henter, J. I. Hemophagocytic lymphohistiocytosis. N. Engl. J. Med. 392, 584\u2013598 (2025).","journal-title":"N. Engl. J. Med."},{"key":"76152_CR46","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.jaci.2022.06.017","volume":"150","author":"Y Tang","year":"2022","unstructured":"Tang, Y. et al. Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis-like hyperinflammation and enhanced myelopoiesis. J. Allergy Clin. Immunol. 150, 1154\u20131167 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"76152_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401061","volume":"11","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. Pan-Cancer single-cell and spatial-resolved profiling reveals the immunosuppressive role of APOE+ macrophages in immune checkpoint inhibitor therapy. Adv. Sci. 11, e2401061 (2024).","journal-title":"Adv. Sci."},{"key":"76152_CR48","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","volume":"106","author":"K Mazodier","year":"2005","unstructured":"Mazodier, K. et al. Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 106, 3483\u20133489 (2005).","journal-title":"Blood"},{"key":"76152_CR49","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1182\/blood.2021014860","volume":"139","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis. Blood 139, 3493\u20133504 (2022).","journal-title":"Blood"},{"key":"76152_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/path.6207","volume":"262","author":"J Thorlacius-Ussing","year":"2024","unstructured":"Thorlacius-Ussing, J. et al. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes. J. Pathol. 262, 22\u201336 (2024).","journal-title":"J. Pathol."},{"key":"76152_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ebiom.2017.10.011","volume":"25","author":"PP Xu","year":"2017","unstructured":"Xu, P. P. et al. A phase II study of methotrexate, etoposide, dexamethasone and pegaspargase sandwiched with radiotherapy in the treatment of newly diagnosed, stage IE to IIE extranodal natural-killer\/T-cell lymphoma, nasal-type. EBioMedicine 25, 41\u201349 (2017).","journal-title":"EBioMedicine"},{"key":"76152_CR52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin, L., Yee, S. W., Kim, R. B. & Giacomini, K. M. SLC transporters as therapeutic targets: emerging opportunities. Nat. Rev. Drug Discov. 14, 543\u2013560 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"76152_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41556-020-00615-4","volume":"23","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. Asparagine enhances LCK signalling to potentiate CD8(+) T-cell activation and anti-tumour responses. Nat. Cell Biol. 23, 75\u201386 (2021).","journal-title":"Nat. Cell Biol."},{"key":"76152_CR54","doi-asserted-by":"publisher","first-page":"e71595","DOI":"10.7554\/eLife.71595","volume":"10","author":"D Sharma","year":"2021","unstructured":"Sharma, D., Yu, Y., Shen, L., Zhang, G. F. & Karner, C. M. SLC1A5 provides glutamine and asparagine necessary for bone development in mice. Elife 10, e71595 (2021).","journal-title":"Elife"},{"key":"76152_CR55","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation, enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell 42, 1370\u20131385.e1379 (2024).","journal-title":"Cancer Cell"},{"key":"76152_CR56","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher, T. N. & Thommen, D. S. Tertiary lymphoid structures in cancer. Science 375, eabf9419 (2022).","journal-title":"Science"},{"key":"76152_CR57","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561\u2013565 (2020).","journal-title":"Nature"},{"key":"76152_CR58","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549\u2013555 (2020).","journal-title":"Nature"},{"key":"76152_CR59","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","volume":"20","author":"SP Kubli","year":"2021","unstructured":"Kubli, S. P., Berger, T., Araujo, D. V., Siu, L. L. & Mak, T. W. Beyond immune checkpoint blockade: emerging immunological strategies. Nat. Rev. Drug Discov. 20, 899\u2013919 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"76152_CR60","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer. Cancer Cell 42, 1268\u20131285.e1267 (2024).","journal-title":"Cancer Cell"},{"key":"76152_CR61","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","volume":"187","author":"LP Andrews","year":"2024","unstructured":"Andrews, L. P. et al. LAG-3 and PD-1 synergize on CD8(+) T cells to drive T cell exhaustion and hinder autocrine IFN-\u03b3-dependent anti-tumor immunity. Cell 187, 4355\u20134372.e4322 (2024).","journal-title":"Cell"},{"key":"76152_CR62","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1182\/blood-2024-203156","volume":"144","author":"Q Cai","year":"2024","unstructured":"Cai, Q. et al. TQB2223 in combination with penpulimab in patients with relapsed or refractory lymphoma: primary analysis of an open-label phase I study. Blood 144, 3047\u20133047 (2024).","journal-title":"Blood"},{"key":"76152_CR63","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-17-0741","volume":"23","author":"A Orillion","year":"2017","unstructured":"Orillion, A. et al. Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma. Clin. Cancer Res. 23, 5187\u20135201 (2017).","journal-title":"Clin. Cancer Res."},{"key":"76152_CR64","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00262-018-2283-0","volume":"68","author":"D Llopiz","year":"2019","unstructured":"Llopiz, D. et al. Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model. Cancer Immunol. Immunother. 68, 379\u2013393 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"76152_CR65","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-024-01825-0","volume":"9","author":"Y Gao","year":"2024","unstructured":"Gao, Y. et al. Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib\/II study. Signal Transduct. Target Ther. 9, 121 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"76152_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"76152_CR67","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00277-016-2805-9","volume":"95","author":"J Jia","year":"2016","unstructured":"Jia, J. et al. Clinical features and survival of extranodal natural killer\/T cell lymphoma with and without hemophagocytic syndrome. Ann. Hematol. 95, 2023\u20132031 (2016).","journal-title":"Ann. Hematol."},{"key":"76152_CR68","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/10428194.2018.1480772","volume":"60","author":"SW Lim","year":"2019","unstructured":"Lim, S. W. et al. Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer\/T-cell lymphoma. Leuk. Lymphoma 60, 317\u2013325 (2019).","journal-title":"Leuk. Lymphoma"},{"key":"76152_CR69","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"76152_CR70","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/S2352-3026(21)00366-5","volume":"9","author":"A Setiadi","year":"2022","unstructured":"Setiadi, A., Zoref-Lorenz, A., Lee, C. Y., Jordan, M. B. & Chen, L. Y. C. Malignancy-associated haemophagocytic lymphohistiocytosis. Lancet Haematol. 9, e217\u2013e227 (2022).","journal-title":"Lancet Haematol."},{"key":"76152_CR71","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","volume":"181","author":"A Deczkowska","year":"2020","unstructured":"Deczkowska, A., Weiner, A. & Amit, I. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell 181, 1207\u20131217 (2020).","journal-title":"Cell"},{"key":"76152_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18546-x","volume":"11","author":"D Xiong","year":"2020","unstructured":"Xiong, D., Wang, Y. & You, M. A gene expression signature of TREM2(hi) macrophages and \u03b3\u03b4 T cells predicts immunotherapy response. Nat. Commun. 11, 5084 (2020).","journal-title":"Nat. Commun."},{"key":"76152_CR73","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00432-020-03301-y","volume":"146","author":"L Zhou","year":"2020","unstructured":"Zhou, L. et al. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome. J. Cancer Res. Clin. Oncol. 146, 3063\u20133074 (2020).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"76152_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn6491","volume":"8","author":"M Grima-Reyes","year":"2022","unstructured":"Grima-Reyes, M. et al. Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression. Sci. Adv. 8, eabn6491 (2022).","journal-title":"Sci. Adv."},{"key":"76152_CR75","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/ajh.26335","volume":"96","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer\/T-cell lymphoma: A multicenter study. Am. J. Hematol. 96, 1481\u20131490 (2021).","journal-title":"Am. J. Hematol."},{"key":"76152_CR76","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1158\/1078-0432.CCR-16-0153","volume":"22","author":"X Li","year":"2016","unstructured":"Li, X. et al. DDGP versus SMILE in newly diagnosed advanced natural killer\/T-cell lymphoma: a randomized controlled, multicenter, open-label study in China. Clin. Cancer Res. 22, 5223\u20135228 (2016).","journal-title":"Clin. Cancer Res."},{"key":"76152_CR77","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","volume":"43","author":"P Kandasamy","year":"2018","unstructured":"Kandasamy, P., Gyimesi, G., Kanai, Y. & Hediger, M. A. Amino acid transporters revisited: New views in health and disease. Trends Biochem Sci. 43, 752\u2013789 (2018).","journal-title":"Trends Biochem Sci."},{"key":"76152_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103614","volume":"72","author":"J Xiong","year":"2021","unstructured":"Xiong, J. et al. SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential. EBioMedicine 72, 103614 (2021).","journal-title":"EBioMedicine"},{"key":"76152_CR79","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2023.10.022","volume":"166","author":"C Hu","year":"2024","unstructured":"Hu, C. et al. Tertiary lymphoid structure-associated B cells enhance CXCL13(+)CD103(+)CD8(+) tissue-resident memory T-cell response to programmed cell death protein 1 blockade in cancer immunotherapy. Gastroenterology 166, 1069\u20131084 (2024).","journal-title":"Gastroenterology"},{"key":"76152_CR80","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan, M. et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 55, 527\u2013541.e525 (2022).","journal-title":"Immunity"},{"key":"76152_CR81","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41423-020-0457-0","volume":"17","author":"L Munoz-Erazo","year":"2020","unstructured":"Munoz-Erazo, L., Rhodes, J. L., Marion, V. C. & Kemp, R. A. Tertiary lymphoid structures in cancer - considerations for patient prognosis. Cell Mol. Immunol. 17, 570\u2013575 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"76152_CR82","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"76152_CR83","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337.e324 (2019).","journal-title":"Cell Syst."},{"key":"76152_CR84","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"76152_CR85","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"76152_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30755-0","volume":"13","author":"D Dimitrov","year":"2022","unstructured":"Dimitrov, D. et al. Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data. Nat. Commun. 13, 3224 (2022).","journal-title":"Nat. Commun."},{"key":"76152_CR87","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang, Z. et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 52, W398\u2013w406 (2024).","journal-title":"Nucleic Acids Res."},{"key":"76152_CR88","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1084\/jem.20082173","volume":"206","author":"DM Kuang","year":"2009","unstructured":"Kuang, D. M. et al. Activated monocytes in the peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med. 206, 1327\u20131337 (2009).","journal-title":"J. Exp. Med."},{"key":"76152_CR89","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41586-023-05771-9","volume":"616","author":"KW Ng","year":"2023","unstructured":"Ng, K. W. et al. Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature 616, 563\u2013573 (2023).","journal-title":"Nature"},{"key":"76152_CR90","doi-asserted-by":"publisher","unstructured":"Cao, Y. Single-cell profiling of natural killer T-cell lymphoma reveals stratified immune features and potential therapeutic implications. Zenodo https:\/\/doi.org\/10.5281\/zenodo.20780871 (2026).","DOI":"10.5281\/zenodo.20780871"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76152-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76152-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76152-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:03:03Z","timestamp":1787914983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76152-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76152"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76152-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9184"}}